Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$24.77 - $29.9 $784,936 - $947,501
-31,689 Reduced 74.32%
10,949 $273,000
Q1 2023

May 15, 2023

SELL
$25.95 - $36.95 $1.57 Million - $2.23 Million
-60,419 Reduced 58.63%
42,638 $1.19 Million
Q4 2022

Feb 09, 2023

BUY
$24.79 - $30.86 $146,261 - $182,074
5,900 Added 6.07%
103,057 $2.68 Million
Q3 2022

Nov 14, 2022

BUY
$24.62 - $32.44 $1.72 Million - $2.26 Million
69,700 Added 253.85%
97,157 $2.52 Million
Q2 2022

Aug 12, 2022

BUY
$19.74 - $29.01 $542,001 - $796,527
27,457 New
27,457 $751,000
Q1 2022

May 13, 2022

SELL
$26.68 - $41.63 $477,411 - $744,927
-17,894 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$33.67 - $43.44 $602,490 - $777,315
17,894 New
17,894 $718,000
Q1 2021

May 14, 2021

SELL
$40.81 - $53.88 $590,683 - $779,859
-14,474 Closed
0 $0
Q4 2020

Feb 02, 2021

BUY
$36.63 - $47.63 $530,182 - $689,396
14,474 New
14,474 $632,000
Q3 2020

Nov 05, 2020

SELL
$30.09 - $43.02 $1.81 Million - $2.58 Million
-60,007 Closed
0 $0
Q2 2020

Jul 22, 2020

BUY
$27.76 - $33.42 $1.47 Million - $1.77 Million
53,092 Added 767.78%
60,007 $1.94 Million
Q1 2020

May 06, 2020

SELL
$20.69 - $37.79 $462,628 - $844,984
-22,360 Reduced 76.38%
6,915 $207,000
Q4 2019

Feb 03, 2020

SELL
$32.75 - $41.43 $1.44 Million - $1.82 Million
-44,004 Reduced 60.05%
29,275 $1.01 Million
Q3 2019

Nov 04, 2019

BUY
$33.73 - $46.27 $2.47 Million - $3.39 Million
73,279 New
73,279 $2.47 Million
Q2 2019

Jul 30, 2019

SELL
$29.6 - $40.93 $2.07 Million - $2.86 Million
-69,783 Closed
0 $0
Q1 2019

May 09, 2019

BUY
$27.85 - $38.09 $1.26 Million - $1.73 Million
45,331 Added 185.39%
69,783 $2.17 Million
Q4 2018

Feb 07, 2019

SELL
$32.39 - $42.05 $1.64 Million - $2.13 Million
-50,555 Reduced 67.4%
24,452 $884,000
Q3 2018

Oct 25, 2018

BUY
$35.69 - $47.65 $383,988 - $512,666
10,759 Added 16.75%
75,007 $2.92 Million
Q2 2018

Aug 02, 2018

BUY
$28.41 - $42.41 $1.83 Million - $2.72 Million
64,248 New
64,248 $2.38 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.09B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.